Bayer AG
XETRA:BAYN
Bayer AG
Long-Term Debt
Bayer AG
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Long-Term Debt
€38.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
21%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Long-Term Debt
$17.9m
|
CAGR 3-Years
108%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Long-Term Debt
€9.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
MPH Health Care AG
XETRA:93M1
|
Long-Term Debt
€21.9k
|
CAGR 3-Years
-81%
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Long-Term Debt
€964m
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Long-Term Debt
€73.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Long-Term Debt?
Long-Term Debt
38.2B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Long-Term Debt amounts to 38.2B EUR.
What is Bayer AG's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
21%
Over the last year, the Long-Term Debt growth was 13%. The average annual Long-Term Debt growth rates for Bayer AG have been 5% over the past three years , and 21% over the past ten years .